Back
Cava Group Vs. BioNTech SE Industry Stock Comparison
Buy
64
CAVA
Cava Group
Last Price:
147.23
Seasonality Move:
36.69%
Buy
52
BNTX
BioNTech SE
Last Price:
110.71
Seasonality Move:
11.8%
Buy
64
Cava Group (CAVA)
is a Buy
Is Cava Group a Buy, Sell or Hold?
- The current Cava Group [CAVA] share price is $147.20. The Score for CAVA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- CAVA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
BioNTech SE (BNTX)
is a Buy
Is BioNTech SE a Buy, Sell or Hold?
- The current BioNTech SE [BNTX] share price is $110.64. The Score for BNTX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- BNTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CAVA Stock Price Chart
What is Cava Group's stock price today?
-
The Cava Group share price today is $147.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
BNTX Stock Price Chart
What is BioNTech SE's stock price today?
-
The BioNTech SE share price today is $110.64
The current trend is relatively stagnant and BNTX is experiencing selling pressure, which indicates risk of future bearish movement.
CAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.58 | Buy |
| Relative Strength Index (14 RSI): | 74.15 | Buy |
| Chaikin Money Flow: | 2018982 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (130.45 - 139.15) | Buy |
| Bollinger Bands (100): | (89.05 - 130.65) | Buy |
BNTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.94 | Sell |
| Relative Strength Index (14 RSI): | 47.5 | Sell |
| Chaikin Money Flow: | -882786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (109.7 - 118.66) | Sell |
| Bollinger Bands (100): | (82.13 - 113.23) | Buy |
CAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 136.39 | Buy |
| 20-day SMA: | 136.17 | Buy |
| 50-day SMA: | 128.28 | Buy |
| 200-day SMA: | 88.4 | Buy |
| 8-day EMA: | 138.75 | Buy |
| 20-day EMA: | 135.46 | Buy |
| 50-day EMA: | 126.83 | Buy |
| 200-day EMA: | 94.08 | Buy |
BNTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.45 | Buy |
| 20-day SMA: | 112.7 | Sell |
| 50-day SMA: | 111.32 | Sell |
| 200-day SMA: | 95.19 | Buy |
| 8-day EMA: | 110.16 | Buy |
| 20-day EMA: | 111.85 | Sell |
| 50-day EMA: | 109.05 | Buy |
| 200-day EMA: | 100.76 | Buy |
Cava Group Earnings Growth & CAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.10 per share.
BioNTech SE Earnings Growth & BNTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.39 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.93 per share, and a decrease next year of $0.45 per share.
Cava Group Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioNTech SE Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||